Gonalves R.V., et al
Representative domains include: Gastrointestinal and hepatic models: Protection against ulcers, leaky gut, IBSlike symptoms, Crohntype inflammation, and toxic liver injury (e.g., CCl4, NSAID, and alcohol models), with improved mucosal healing and barrier integrity
The route of administration depends on your primary goal: For GI support: Oral BPC-157 (typically 250 to 500 mcg taken on an empty stomach once or twice daily) targets the gastrointestinal tract directly
Boosting your metabolism for enhanced energy and recovery
Animals began treatment ~26 days post induction, and survival was recorded as days post-tumour induction at which the clinical endpoint was reached
Warnings: Should not be consumed if you are consuming other products containing green tea on the same day